RISK STRATIFICATION WITH PRE-TREATMENT METABOLITE RISK SCORE FOR CARFILZOMIB-RELATED CARDIOTOXICITY IN MULTIPLE MYELOMA PATIENTS.

被引：0
|
作者：
Nguyen, T. [1 ]
Tantawy, M. [1 ]
Zhou, Y. [1 ]
Rubinstein, S. [2 ]
Garrett, T. [1 ]
Baz, R. [3 ]
Fradley, M. [4 ]
Lu, Q. [1 ]
Lenihan, D. [5 ]
Cornell, R. [6 ]
Gong, Y. [1 ]
机构：
[1] Univ Florida, Gainesville, FL USA
[2] Univ N Carolina, Chapel Hill, NC 27515 USA
[3] H Lee Moffitt Canc Ctr Res Inst, Tampa, FL USA
[4] Univ Penn, Philadelphia, PA 19104 USA
[5] Washington Univ, St Louis, MO 63110 USA
[6] Abb Vie, Chicago, IL USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2022年 / 111卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PT-014
引用
收藏
页码：S66 / S66
页数：1
相关论文
共 50 条
  • [31] Current and future biomarkers for risk-stratification and treatment personalisation in multiple myeloma
    Le, Giao N.
    Bones, Jonathan
    Coyne, Mark
    Bazou, Despina
    Dowling, Paul
    O'Gorman, Peter
    Larkin, Anne-Marie
    MOLECULAR OMICS, 2019, 15 (01) : 7 - 20
  • [32] Individualized Treatment-Adjusted Risk Stratification in Newly Diagnosed Multiple Myeloma
    Maura, Francesco
    Rajanna, Arjun Raj
    Derkach, Andriy
    Ziccheddu, Bachisio
    Weinhold, Niels
    Maclachlan, Kylee H.
    Diamond, Benjamin
    Davies, Faith E.
    Boyle, Eileen
    Walker, Brian A.
    Poos, Alexandra M.
    Hultcrantz, Malin
    Silva, Ariosto Siqueira
    Hampton, Oliver
    Teer, Jamie
    Bolli, Niccolo
    Jackson, Graham
    Kaiser, Martin F.
    Pawlyn, Charlotte
    Cook, Gordon
    Verducci, Dennis
    Kazandjian, Dickran
    van Rhee, Frits
    Usmani, Saad
    Shain, Ken H.
    Raab, Marc S.
    Morgan, Gareth J.
    Landgren, Ola
    BLOOD, 2022, 140 : 1561 - 1563
  • [33] Does a Multiple Myeloma Polygenic Risk Score Predict Overall Survival of Patients with Myeloma?
    Macauda, Angelica
    Clay-Gilmour, Alyssa
    Hielscher, Thomas
    Hildebrandt, Michelle A. T.
    Kruszewski, Marcin
    Orlowski, Robert Z.
    Kumar, Shaji K.
    Ziv, Elad
    Orciuolo, Enrico
    Brown, Elizabeth E.
    Forsti, Asta
    Waller, Rosalie G.
    Machiela, Mitchell J.
    Chanock, Stephen J.
    Camp, Nicola J.
    Rymko, Marcin
    Rany, Malgorzata
    Cozen, Wendy
    Varkonyi, Judit
    Piredda, Chiara
    Pelosini, Matteo
    Belachew, Alem A.
    Subocz, Edyta
    Hemminki, Kari
    Rybicka-Ramos, Malwina
    Giles, Graham G.
    Milne, Roger L.
    Hofmann, Jonathan N.
    Zaucha, Jan Maciej
    Vangsted, Annette Juul
    Goldschmidt, Hartmut
    Rajkumar, S. Vincent
    Tomczak, Waldemar
    Sainz, Juan
    Butrym, Aleksandra
    Watek, Marzena
    Iskierka-Jazdzewska, Elzbieta
    Buda, Gabriele
    Robinson, Dennis P.
    Jurczyszyn, Artur
    Dudzinski, Marek
    Martinez-Lopez, Joaquin
    Sinnwell, Jason P.
    Slager, Susan L.
    Jamroziak, Krzysztof
    Reis, Rui Manuel Vieira
    Weinhold, Niels
    Bhatti, Parveen
    Carvajal-Carmona, Luis G.
    Zawirska, Daria
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (09) : 1863 - 1866
  • [34] Arterial Hypertension and Multiple Myeloma: Physiopathology and Cardiovascular Risk and 'Practical' Indications in Patients Receiving Carfilzomib
    Milan, Alberto
    Bruno, Giulia
    Maffei, Ilaria
    Iannaccone, Andrea
    Ravera, Agnese
    Schiavone, Domenica
    Veglio, Franco
    CURRENT HYPERTENSION REVIEWS, 2019, 15 (01) : 47 - 53
  • [35] RISK OF HEART FAILURE WITH CARFILZOMIB IN PATIENTS WITH MULTIPLE MYELOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Paz, Pablo
    Vutthikraivit, Wasawat
    Mantilla, Barbara
    El Nawaa, Saif
    Wongsanegsak, Sally
    Elmassry, Mohamed
    Rahman, M. Rubayat
    Whisenant, Ty
    Ball, Somedeb
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 986 - 986
  • [36] Methodology of a Novel Risk Stratification Algorithm for Patients with Multiple Myeloma in the Relapsed Setting
    Bouwmeester, Walter
    Briggs, Andrew
    van Hout, Ben
    Hajek, Roman
    Gonzalez-McQuire, Sebastian
    Campioni, Marco
    DeCosta, Lucy
    Brozova, Lucie
    ONCOLOGY AND THERAPY, 2019, 7 (02) : 141 - 157
  • [37] The prognostic utility of dynamic risk stratification at disease progression in patients with multiple myeloma
    Fan, Huihsou
    Yan, Wenqiang
    Li, Lingna
    Xu, Jingyu
    Liu, Jiahui
    Xu, Yan
    Sui, Weiwei
    Deng, Shuhui
    Du, Chenxing
    Yi, Shuhua
    Zou, Dehui
    Qiu, Lugui
    An, Gang
    HEMATOLOGY, 2023, 28 (01)
  • [38] Methodology of a Novel Risk Stratification Algorithm for Patients with Multiple Myeloma in the Relapsed Setting
    Walter Bouwmeester
    Andrew Briggs
    Ben van Hout
    Roman Hájek
    Sebastian Gonzalez-McQuire
    Marco Campioni
    Lucy DeCosta
    Lucie Brozova
    Oncology and Therapy, 2019, 7 : 141 - 157
  • [39] Clinical Features and Risk Stratification of Multiple Myeloma Patients with COVID-19
    Zheng, Ruifang
    Mieth, Kelsey
    Bennett, Christen
    Miller, Carol
    Anderson, Larry D.
    Chen, Mingyi
    Cao, Jing
    CANCERS, 2023, 15 (14)
  • [40] Treatment patterns and outcomes according to cytogenetic risk stratification in patients with multiple myeloma: a real-world analysis
    Shebli Atrash
    Evelyn M. Flahavan
    Tao Xu
    Esprit Ma
    Sudeep Karve
    Wan-Jen Hong
    Gilbert Jirau-Lucca
    Michael Nixon
    Sikander Ailawadhi
    Blood Cancer Journal, 12
12345